Sleep, feeding, and neuropeptides: Roles of orexins and orexin receptors

Current Opinion in Neurobiology

Volumn 12, Issue 3, 2002, Pages 339-345

  Mieda, Michihiro ^a   Yanagisawa, Masashi ^a,b  

^a UNIVERSITY OF TEXAS AT DALLAS   (United States)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

G PROTEIN COUPLED RECEPTOR; NEUROPEPTIDE; OREXIN; OREXIN RECEPTOR; UNCLASSIFIED DRUG;

ENERGY BALANCE; FEEDING; NARCOLEPSY; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION; SLEEP WAKING CYCLE;

EID: 0036606107     PISSN: 09594388     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-4388(02)00331-8     Document Type: Review

References (53)

1. Narcolepsy
2. Orexins and orexin receptors: A family of hypothalamic neuropeptides and G-protein-coupled receptors that regulate feeding behavior
3. To eat or to sleep? Orexin in the regulation of feeding and wakefulness
4. The hypocretins: Hypothalamus-specific peptides with neuroexcitatory activity
5. Presynaptic and postsynaptic actions and modulation of neuroendocrine neurons by a new hypothalamic peptide, hypocretin/orexin
6. Distribution of orexin neurons in the adult rat brain
7. Neurons containing hypocretin (orexin) project to multiple neuronal systems
8. Orexins, orexigenic hypothalamic peptides, interact with autonomic, neuroendocrine and neuroregulatory systems
9. Hypothalamic hypocretin (orexin): Robust innervation of the spinal cord
10. Distribution of orexin receptor mRNA in the rat brain
11. Differential distribution and regulation of OX1 and OX2 orexin/hypocretin receptor messenger RNA in the brain upon fasting
12. Differential expression of orexin receptors 1 and 2 in the rat brain
13. Narcolepsy in orexin knockout mice: Molecular genetics of sleep regulation
14. The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene
15. Low cerebrospinal fluid hypocretin (Orexin) and altered energy homeostasis in human narcolepsy
16. A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains
17. Reduced number of hypocretin neurons in human narcolepsy
18. 2R) knockout mice
19. Narcoleptic behavioral arrests in orexin ligand and orexin-2 receptor knockout mice are neurophysiologically distinct
20. Behavioral and polysomnographic characterization of orexin-1 receptor and orexin-2 receptor double knockout mice
21. Genetic ablation of orexin neurons in mice results in narcolepsy, hypophagia, and obesity
22. Physiology of REM sleep, cataplexy, and sleep paralysis
23. The sleep switch: Hypothalamic control of sleep and wakefulness
24. Hypocretin (orexin) activation and synaptic innervation of the locus coeruleus noradrenergic system
25. Orexins/hypocretins excite basal forebrain cholinergic neurones
26. Arousal effect of orexin A depends on activation of the histaminergic system
27. Orexin A activates locus coeruleus cell firing and increases arousal in the rat
28. Hypocretin-1 modulates rapid eye movement sleep through activation of locus coeruleus neurons
29. Wake-promoting and sleep-suppressing actions of hypocretin (orexin): Basal forebrain sites of action
30. Effects of lateral preoptic area application of orexin-A on sleep-wakefulness
31. Orexin A excites serotonergic neurons in the dorsal raphe nucleus of the rat
32. Orexins (hypocretins) directly excite tuberomammillary neurons
33. Orexin/hypocretin excites the histaminergic neurons of the tuberomammillary nucleus
34. Hypocretin/orexin, sleep and narcolepsy
35. Fos expression in orexin neurons varies with behavioral state
36. The hypocretin/orexin ligand-receptor system: Implications for sleep and sleep disorders
37. Increased and decreased muscle tone with orexin (hypocretin) microinjections in the locus coeruleus and pontine inhibitory area
38. The effect of the orexins on food intake: Comparison with neuropeptide Y, melanin-concentrating hormone and galanin
39. Effects of single and chronic intracerebroventricular administration of the orexins on feeding in the rat
40. Effect of lateral cerebroventricular injection of the appetite-stimulating neuropeptide, orexin and neuropeptide Y, on the various behavioral activities of rats
41. Chronic intracerebroventricular administration of orexin-A to rats increases food intake in daytime, but has no effect on body weight
42. Independent feeding and metabolic actions of orexins in mice
43. Metabolic characterization of orexin knockout mice
44. Hypocretin/orexin- and melanin-concentrating hormone-expressing cells form distinct populations in the rodent lateral hypothalamus: Relationship to the neuropeptide Y and agouti gene-related protein systems
45. Chemically defined projections linking the mediobasal hypothalamus and the lateral hypothalamic area
46. Synaptic interaction between hypocretin (orexin) and neuropeptide Y cells in the rodent and primate hypothalamus: A novel circuit implicated in metabolic and endocrine regulations
47. Neurons containing orexin in the lateral hypothalamic area of the adult rat brain are activated by insulin-induced acute hypoglycemia
48. Hypoglycemia activates orexin neurons and selectively increases hypothalamic orexin-B levels: Responses inhibited by feeding and possibly mediated by the nucleus of the solitary tract
49. The hypocretin/orexin story
50. Orexins and orexin receptors: Implication in feeding behavior
51. Heterozygosity at the canarc-1 locus can confer susceptibility for narcolepsy: Induction of cataplexy in heterozygous asymptomatic dogs after administration of a combination of drugs acting on monoaminergic and cholinergic systems
52. Pharmacological aspects of human and canine narcolepsy
53. Decreased brain histamine content in hypocretin/orexin receptor-2 mutated narcoleptic dogs